Thrivent Financial for Lutherans Sells 33,264 Shares of Tenet Healthcare Corporation $THC

Thrivent Financial for Lutherans lessened its stake in Tenet Healthcare Corporation (NYSE:THC) by 35.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 61,175 shares of the company’s stock after selling 33,264 shares during the quarter. Thrivent Financial for Lutherans’ holdings in Tenet Healthcare were worth $12,173,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. NewEdge Advisors LLC increased its stake in shares of Tenet Healthcare by 6.1% in the 1st quarter. NewEdge Advisors LLC now owns 2,890 shares of the company’s stock valued at $389,000 after acquiring an additional 166 shares during the last quarter. Jones Financial Companies Lllp boosted its stake in Tenet Healthcare by 299.1% during the 1st quarter. Jones Financial Companies Lllp now owns 1,700 shares of the company’s stock worth $229,000 after acquiring an additional 1,274 shares during the last quarter. Sivia Capital Partners LLC bought a new stake in Tenet Healthcare in the second quarter valued at approximately $290,000. Quantbot Technologies LP acquired a new stake in Tenet Healthcare in the second quarter worth $65,000. Finally, Amundi boosted its position in shares of Tenet Healthcare by 4,207.8% during the second quarter. Amundi now owns 27,010 shares of the company’s stock worth $4,652,000 after purchasing an additional 26,383 shares in the last quarter. 95.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, EVP Thomas W. Arnst sold 8,000 shares of the stock in a transaction that occurred on Monday, March 9th. The stock was sold at an average price of $238.85, for a total value of $1,910,800.00. Following the completion of the sale, the executive vice president owned 12 shares of the company’s stock, valued at approximately $2,866.20. This represents a 99.85% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Paola M. Arbour sold 6,500 shares of the business’s stock in a transaction on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the transaction, the executive vice president owned 29,291 shares in the company, valued at approximately $6,983,853.13. The trade was a 18.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 46,517 shares of company stock worth $10,943,111. Corporate insiders own 0.97% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a research note on Wednesday, March 4th. Wells Fargo & Company lowered their price target on Tenet Healthcare from $265.00 to $213.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Leerink Partners lifted their price objective on Tenet Healthcare from $255.00 to $264.00 and gave the company an “outperform” rating in a report on Friday, February 20th. Barclays lowered their target price on Tenet Healthcare from $257.00 to $238.00 and set an “overweight” rating for the company in a research note on Tuesday, May 5th. Finally, Stephens reduced their price target on shares of Tenet Healthcare from $275.00 to $260.00 and set an “overweight” rating for the company in a report on Monday, May 4th. Nineteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $244.16.

Tenet Healthcare Trading Down 2.1%

NYSE:THC opened at $192.50 on Tuesday. The company has a quick ratio of 1.30, a current ratio of 1.36 and a debt-to-equity ratio of 1.96. Tenet Healthcare Corporation has a twelve month low of $146.60 and a twelve month high of $247.21. The company has a market cap of $16.58 billion, a P/E ratio of 10.01, a price-to-earnings-growth ratio of 1.30 and a beta of 1.30. The business has a 50 day moving average price of $198.47 and a two-hundred day moving average price of $203.57.

Tenet Healthcare (NYSE:THC) last announced its quarterly earnings data on Thursday, April 30th. The company reported $4.82 EPS for the quarter, topping analysts’ consensus estimates of $4.21 by $0.61. Tenet Healthcare had a net margin of 7.94% and a return on equity of 25.55%. The business had revenue of $5.37 billion for the quarter, compared to analyst estimates of $5.39 billion. During the same quarter in the previous year, the firm posted $4.36 earnings per share. The firm’s revenue for the quarter was up 2.6% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.380-18.68 EPS. As a group, analysts expect that Tenet Healthcare Corporation will post 17.64 EPS for the current fiscal year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.